Veracyte (VCYT) Operating Margin (2012 - 2026)

Veracyte has reported Operating Margin for 15 years, with the latest figure at 15.29% in Q2 2026.

• Operating Margin for Q2 2026 came in at 15.29%, up 1933.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 18.82% (up 1594.0% YoY), and the FY2025 annual result was 11.17%, up 755.0% from the prior year.
• Operating Margin slipped to 15.29% in Q2 2026, from 16.28% in the prior quarter.
• Over five years, Operating Margin peaked at 26.45% in Q4 2025 and troughed at 36.16% in Q4 2023.
• A 5-year average of 3.49% and a median of 4.43% in 2024 frame the typical range for Operating Margin.
• The widest annual swing landed in 2022, when Operating Margin soared 10124 bps; it then plunged 2941 bps in 2023.
• A 5-year view of Operating Margin shows it stood at 6.75% in 2022, then sank by 436 bps to 36.16% in 2023, then surged by 110 bps to 3.52% in 2024, then soared by 652 bps to 26.45% in 2025, then sank by 42 bps to 15.29% in 2026.
• Per Business Quant data, the three most recent Operating Margin figures were 15.29% in Q2 2026, 16.28% in Q1 2026, and 26.45% in Q4 2025.